Polarityte Inc  

(Public, NASDAQ:COOL)   Watch this stock  
Find more results for COOL
7.15
+0.65 (10.00%)
After Hours: 7.11 -0.04 (-0.56%)
Feb 23, 6:57PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.26 - 8.38
52 week 2.61 - 8.38
Open 6.33
Vol / Avg. 0.00/73,151.00
Mkt cap 30.77M
P/E     -
Div/yield 2.01
EPS -5.67
Shares 4.25M
Beta 0.88
Inst. own 4%

Key stats and ratios

Q4 (Oct '16) 2016
Net profit margin -181.25% -300.91%
Operating margin -233.93% -318.16%
EBITD margin - -306.68%
Return on average assets -23.50% -38.01%
Return on average equity - -10282.13%
Employees 62 -
CDP Score - -

Address

4041 Hadley Rd Ste T
SOUTH PLAINFIELD, NJ 07080-1111
United States - Map
+1-732-2258910 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PolarityTE, Inc., formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. The Company's PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. The Company focuses on various products, including SkinTE, OsteoTE, AngioTE, MyoTE, CartTE, AdiposeTE and NeuralTE. The Company, through SkinTE, is focused on supplying an autologous construct to regenerate a patient’s skin due to a variety of injuries and conditions.

Officers and directors

Denver Lough Chairman of the Board, Chief Executive Officer, Chief Scientific Officer
Age: 35
Bio & Compensation  - Reuters
John Stetson Chief Financial Officer, Executive Vice President, Secretary, Director
Age: 31
Bio & Compensation  - Reuters
Edward Winslow Swanson M.D. Chief Operating Officer, Director
Age: 31
Bio & Compensation  - Reuters
Michael Neumeister Chief Medical Officer
Age: 55
Bio & Compensation  - Reuters
Mohit Bhansali Director
Age: 40
Bio & Compensation  - Reuters
Michael Martin Beeghley Independent Director
Age: 48
Bio & Compensation  - Reuters
Steven Gorlin Independent Director
Age: 79
Bio & Compensation  - Reuters
Jon Mogford Ph.D. Independent Director
Age: 48
Bio & Compensation  - Reuters